Christophe Mellon

Christophe Mellon, PhD

Vice-President CMC

BIOGRAPHY

After organic chemistry training at Université de Montréal and a post-doc at MIT, at Merck Frosst Christophe contributed to start medicinal chemistry programs, revamp the treatment of animal biological samples, became deeply involved in metabolism and original animal dosing while conducting successful drug discovery, which helped three molecules advance in pre-clinical evaluations. Hired as Associate Director at Thallion Pharmaceuticals, he was responsible for leading and managing internal organic and analytical chemistry inventing a GMP route for a clinical candidate, as well as significantly improving the formulation of their peptide candidate. As Associate Director at OmegaChem, he was responsible for the operation of their satellite site where 20 chemists served the pharmaceutical industry internationally for 5 years. In 2015, he joined SiliCycle inc., where he became a key person for the creation of its subsidiary company Total Ocean as technology inventor, investor and board member. He then transitioned to the role of General Manager at another SiliCycle’s subsidiary, Mirakapon Inc., in the material science industry. In 2021, he then joined Giiant Pharma as VP Discovery and Chemistry before taking the role of CEO in January 2023. After successfully finding a partner and leading the lead molecule to a CTA in September 2024, he now operates as a CMC expert.

back to team